China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Operating Margin
China Resources Boya Bio pharmaceutical Group Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CN |
Market Cap | 17.2B CNY |
Operating Margin |
9%
|
Country | US |
Market Cap | 288.9B USD |
Operating Margin |
30%
|
Country | US |
Market Cap | 168.6B USD |
Operating Margin |
24%
|
Country | US |
Market Cap | 113B USD |
Operating Margin |
39%
|
Country | US |
Market Cap | 106.9B USD |
Operating Margin |
30%
|
Country | AU |
Market Cap | 138.6B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 84.5B USD |
Operating Margin |
32%
|
Country | US |
Market Cap | 50.6B USD |
Operating Margin |
-100%
|
Country | US |
Market Cap | 43.1B USD |
Operating Margin |
-33%
|
Country | US |
Market Cap | 33.5B USD |
Operating Margin |
22%
|
Country | KR |
Market Cap | 40T KRW |
Operating Margin |
30%
|
Profitability Report
View the profitability report to see the full profitability analysis for China Resources Boya Bio pharmaceutical Group Co Ltd.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on China Resources Boya Bio pharmaceutical Group Co Ltd's most recent financial statements, the company has Operating Margin of 9.2%.